Cite
HARVARD Citation
Dimopoulos, K. et al. (2018). Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon‐independent manner. Molecular oncology. 12 (2), pp. 180-195. [Online].